Propofol
- Generic Name
- Propofol
- Brand Names
- Diprivan
- Drug Type
- Small Molecule
- Chemical Formula
- C12H18O
- CAS Number
- 2078-54-8
- Unique Ingredient Identifier
- YI7VU623SF
- Background
Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
- Indication
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
- Associated Conditions
- -
- Associated Therapies
- Induction of anesthesia therapy, Maintenance of anesthesia therapy, Monitored anesthesia care sedation, Sedative therapy
REmimazolam vs PrOpofol on Intraoperative hypotenSion in Major Noncardiac surgEry
- First Posted Date
- 2022-06-29
- Last Posted Date
- 2022-10-03
- Lead Sponsor
- Nanfang Hospital, Southern Medical University
- Target Recruit Count
- 340
- Registration Number
- NCT05436522
- Locations
- 🇨🇳
Nanfang Hospital, Southern Medical University, Guangzhou, China
Comparison of Recovery From General Anesthesia in Remimazolam With Flumazenil vs. Propofol
- Conditions
- Interventions
- First Posted Date
- 2022-06-28
- Last Posted Date
- 2023-01-13
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 66
- Registration Number
- NCT05435911
- Locations
- 🇰🇷
Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul, Korea, Republic of
QT Distance and P Dispersion in ECG in Patients Having Bronchoscopy in the ICU
- Conditions
- Interventions
- First Posted Date
- 2022-06-28
- Last Posted Date
- 2023-01-31
- Lead Sponsor
- Abant Izzet Baysal University
- Target Recruit Count
- 40
- Registration Number
- NCT05434624
- Locations
- 🇹🇷
Abant izzet baysal university, Bolu, Turkey
Explore the Advantages of Remimazolam Used on Gastroscopy
- Conditions
- Interventions
- First Posted Date
- 2022-06-23
- Last Posted Date
- 2022-06-23
- Lead Sponsor
- Sichuan Provincial People's Hospital
- Target Recruit Count
- 287
- Registration Number
- NCT05429086
Effect of Remimazolam and Propofol on Hemodynamic Stability During Anesthesia Induction in OPCAB Patients
- Conditions
- Interventions
- First Posted Date
- 2022-06-21
- Last Posted Date
- 2023-11-22
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 106
- Registration Number
- NCT05423951
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Propofol and Dexmedetomidin vs Midazolam Intraoperative Sedation and POCD
- Conditions
- Interventions
- First Posted Date
- 2022-06-01
- Last Posted Date
- 2023-07-18
- Lead Sponsor
- Osijek University Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT05398757
- Locations
- 🇭🇷
University Hospital Osijek, Osijek, Croatia
Comparison of Remimazolam With Flumazenil vs. Propofol During RFCA for Atrial Fibrillation
- Conditions
- Interventions
- First Posted Date
- 2022-05-31
- Last Posted Date
- 2023-11-22
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 54
- Registration Number
- NCT05397886
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Remimazolam Versus Propopol Based Total Intravenous Anesthesia for Breast Surgery
- First Posted Date
- 2022-05-17
- Last Posted Date
- 2024-11-28
- Lead Sponsor
- Seoul National University Hospital
- Registration Number
- NCT05375747
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
The Application of Remazolam in Gastroenteroscopy
- First Posted Date
- 2022-05-02
- Last Posted Date
- 2022-05-02
- Lead Sponsor
- Yangzhou University
- Target Recruit Count
- 160
- Registration Number
- NCT05357430
- Locations
- 🇨🇳
Affiliated Hospital of Yangzhou University, Yangzhou, Jiangsu, China
Impact of Anesthesia Maintenance Methods on 5-year Survival After Surgery
- Conditions
- Interventions
- First Posted Date
- 2022-04-25
- Last Posted Date
- 2022-05-02
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 1228
- Registration Number
- NCT05343260
- Locations
- 🇨🇳
Cancer Hospital of Guangxi Medical University, Nanning, Guangxi, China
🇨🇳The Third Xiangya Hospital of Central South University, Changsha, Hunan, China
🇨🇳Beijing Shijitan Hospital, Beijing, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.